Molecular multitasking: Statins lead to more arteries, less plaque

Nature Medicine

Volumn 6, Issue 9, 2000, Pages 965-966

  Simons, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PRAVASTATIN; PROTEIN KINASE; SIMVASTATIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL LINE; DRUG MECHANISM; HYPERCHOLESTEROLEMIA; LIMB ISCHEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; ENZYME ACTIVATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC-OXIDE SYNTHASE; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SIMVASTATIN;

EID: 0033827102     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/79646     Document Type: Article

References (10)

1. Vaughan, C.J., Murphy, M.B. & Buckley, B.M. Statins do more than just lower cholesterol. Lancet 348, 1079-1082 (1996).
2. Davignon, J. & Laaksonen, R. Low-density lipoprotein-independent effects of statins. Curr. Opin. Lipidol. 10, 543-559 (1999).
3. Kureishi, Y. et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Med. 6, 1004-1010
4. Dimmeler, S. & Zeiher, A.M. Akt takes center stage in angiogenesis signaling. Circ. Res. 86, 4-5 (2000).
5. Jiang, B.H., Zheng, J.Z., Aoki, M. & Vogt, P.K. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97, 1749-1753 (2000).
6. Eliceiri, B.P. et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 4, 915-924 (1999).
7. Endres, M. et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 95, 8880-8885 (1998).
8. Lefer, A.M. et al. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100, 178-184 (1999).
9. Laufs, U., La Fata, V., Plutzky, J. & Liao, J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135 (1998).
10. Lopez, J. et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am. J. Physiol. 273, H1317-1323 (1997).